Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis

Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis

Tuberculosis remains a serious threat worldwide. For this reason, it is necessary to identify agents that shorten the duration of treatment, strengthen the host immune system, and/or decrease the damage caused by the infection. Statins are drugs that reduce plasma cholesterol levels and have immunom...

Full description

Bibliographic Details
Main Authors: Paola Del Carmen Guerra-De-Blas, Miriam Bobadilla-Del-Valle, Isabel Sada-Ovalle, Iris Estrada-García, Pedro Torres-González, Alejandro López-Saavedra, Silvia Guzmán-Beltrán, Alfredo Ponce-de-León, José Sifuentes-Osornio
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Microbiology
Subjects:
simvastatin
tuberculosis
immune response
cytokines
autophagy
apoptosis
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.02097/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2019.02097/full

Similar Items